Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-24T15:33:19.624Z Has data issue: false hasContentIssue false

Promoting coronavirus disease 2019 (COVID-19) vaccination among healthcare personnel: A multifaceted intervention at a tertiary-care center in Japan

Published online by Cambridge University Press:  21 July 2021

Akane Takamatsu
Affiliation:
Division of Infectious Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan Department of Infection Control, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan
Hitoshi Honda*
Affiliation:
Division of Infectious Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan Department of Infection Control, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan
Tomoya Kojima
Affiliation:
Department of Infection Control, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan
Kengo Murata
Affiliation:
Department of Respiratory and Medical Oncology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan
Hilary M. Babcock
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, United States
*
Author for correspondence: Hitoshi Honda, MD, PhD, E-mail: [email protected]

Abstract

Objective:

The coronavirus disease 2019 (COVID-19) vaccine may hold the key to ending the pandemic, but vaccine hesitancy is hindering the vaccination of healthcare personnel (HCP). We examined their perceptions of the COVID-19 vaccine and implemented an intervention to increase vaccination uptake.

Design:

Before-and-after trial.

Participants and setting:

Healthcare personnel at a 790-bed tertiary-care center in Tokyo, Japan.

Interventions:

A prevaccination questionnaire was administered to HCP to examine their perceptions of the COVID-19 vaccine. A multifaceted intervention was then implemented involving (1) distribution of informational leaflets to all HCP, (2) hospital-wide announcements encouraging vaccination, (3) a mandatory lecture, (4) an educational session about the vaccine for pregnant or breastfeeding HCP, and (5) allergy testing for HCP at risk of allergic reactions to the vaccine. A postvaccination survey was also performed.

Results:

Of 1,575 HCP eligible for enrollment, 1,224 (77.7%) responded to the questionnaire, 533 (43.5%) expressed willingness to be vaccinated, 593 (48.4%) were uncertain, and 98 (8.0%) expressed unwillingness to be vaccinated. The latter 2 groups were concerned about the vaccine’s safety rather than its efficacy. After the intervention, the overall vaccination rate reached 89.7% (1,413 of 1,575), and 88.9% (614 of 691) of the prevaccination survey respondents answered “unwilling” to or “unsure” about eventually receiving a vaccination. In the postvaccination questionnaire, factors contributing to increased COVID-19 vaccination included information and endorsement of vaccination at the medical center (274 of 1,037, 26.4%).

Conclusions:

This multifaceted intervention increased COVID-19 vaccinations among HCP at a Japanese hospital. Frequent support and provision of information were crucial for increasing the vaccination rate and may be applicable to the general population as well.

Type
Original Article
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Coronavirus (COVID-19) vaccinations. OurWorldInData.org. https://ourworldindata.org/covid-vaccinations. Accessed April 29, 2021.Google Scholar
Details of the vaccine for COVID-19. https://www.mhlw.go.jp/content/000740417.pdf. Published 2021. Accessed March 21, 2021.Google Scholar
Polack, FP, Thomas, SJ, Kitchin, N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 2020;383:26032615.CrossRefGoogle ScholarPubMed
Dagan, N, Barda, N, Kepten, E, et al. BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting. N Engl J Med 2021;384:14121423.CrossRefGoogle Scholar
Fisher, KA, Bloomstone, SJ, Walder, J, Crawford, S, Fouayzi, H, Mazor, KM. Attitudes toward a potential SARS-CoV-2 vaccine: a survey of US adults. Ann Intern Med 2020;173:964973.CrossRefGoogle Scholar
Dror, AA, Eisenbach, N, Taiber, S, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol 2020;35:775779.CrossRefGoogle ScholarPubMed
Wong, LP, Wong, PF, AbuBakar S. Vaccine hesitancy and the resurgence of vaccine preventable diseases: the way forward for Malaysia, a Southeast Asian country. Hum Vaccin Immunother 2020;16:15111520.CrossRefGoogle ScholarPubMed
Shimizu, K, Sorano, S, Iwai, K. Vaccine hesitancy in Japan: is the country well prepared for Tokyo 2020? Travel Med Infect Dis 2020;34:101609.CrossRefGoogle ScholarPubMed
Grumbach, K, Judson, T, Desai, M, et al. Association of race/ethnicity with likeliness of COVID-19 vaccine uptake among health workers and the general population in the San Francisco Bay area. JAMA Intern Med 2021;181:10081011.CrossRefGoogle Scholar
Shekhar, R, Sheikh, AB, Upadhyay, S, et al. COVID-19 vaccine acceptance among healthcare workers in the United States. Vaccines (Basel) 2021;9:119.CrossRefGoogle ScholarPubMed
Qattan, AMN, Alshareef, N, Alsharqi, O, Al Rahahleh, N, Chirwa, GC, Al-Hanawi, MK. Acceptability of a COVID-19 vaccine among healthcare workers in the Kingdom of Saudi Arabia. Front Med (Lausanne) 2021;8:644300.CrossRefGoogle ScholarPubMed
Di Gennaro, F, Murri, R, Segala, FV, et al. Attitudes towards anti–SARS-CoV2 vaccination among healthcare workers: results from a national survey in Italy. Viruses 2021;13:371.CrossRefGoogle ScholarPubMed
Lazarus, JV, Ratzan, SC, Palayew, A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 2021;27:225228.CrossRefGoogle ScholarPubMed
Machida, M, Nakamura, I, Kojima, T, et al. Acceptance of a COVID-19 vaccine in Japan during the COVID-19 pandemic. Vaccines (Basel) 2021;9:210.CrossRefGoogle ScholarPubMed
Laine, C, Cotton, D, Moyer, DV. COVID-19 vaccine: promoting vaccine acceptance. Ann Intern Med 2021;174:252253.CrossRefGoogle ScholarPubMed
Montagni, I, Ouazzani-Touhami, K, Mebarki, A, et al. Acceptance of a COVID-19 vaccine is associated with ability to detect fake news and health literacy. J Public Health (Oxf) 2021. doi: 10.1093/pubmed/fdab028.CrossRefGoogle Scholar
Patel, M. Test behavioural nudges to boost COVID immunization. Nature 2021;590:185.CrossRefGoogle ScholarPubMed
Wood, S, Schulman, K. Beyond politics—promoting COVID-19 vaccination in the United States. N Engl J Med 2021;384:e23.CrossRefGoogle ScholarPubMed
Finney Rutten, LJ, Zhu, X, Leppin, AL, et al. Evidence-based strategies for clinical organizations to address COVID-19 vaccine hesitancy. Mayo Clin Proc 2021;96:699707.CrossRefGoogle ScholarPubMed
Babcock, HM, Gemeinhart, N, Jones, M, Dunagan, WC, Woeltje, KF. Mandatory influenza vaccination of healthcare workers: translating policy to practice. Clin Infect Dis 2010;50:459464.CrossRefGoogle ScholarPubMed
Paterlini, M. COVID-19: Italy makes vaccination mandatory for healthcare workers. BMJ 2021;373:n905.CrossRefGoogle ScholarPubMed
Ledda, C, Costantino, C, Cuccia, M, Maltezou, HC, Rapisarda, V. Attitudes of healthcare personnel towards vaccinations before and during the COVID-19 pandemic. Int J Environ Res Public Health 2021. doi: 10.3390/ijerph18052703.CrossRefGoogle Scholar
Lovelace, B Jr Pfizer CEO says third COVID vaccine dose likely needed within 12 months. CNBC. April 15, 2021.Google Scholar
Schwarzinger, M, Verger, P, Guerville, MA, et al. Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public? Vaccine 2010;28:27432748.CrossRefGoogle ScholarPubMed
Nowak, GJ, Sheedy, K, Bursey, K, Smith, TM, Basket, M. Promoting influenza vaccination: insights from a qualitative meta-analysis of 14 years of influenza-related communications research by US Centers for Disease Control and Prevention (CDC). Vaccine 2015;33:27412756.CrossRefGoogle Scholar
Supplementary material: File

Takamatsu et al. supplementary material

Takamatsu et al. supplementary material

Download Takamatsu et al. supplementary material(File)
File 1.1 MB